Showing results (11-20 of 27) with videos related to

Sort By:
Pageof 3
European Journal of Nuclear Medicine and Molecular Imaging|January 27, 2012
Comparison of 3'-deoxy-3'-[¹⁸F]fluorothymidine positron emission tomography (FLT PET) and FDG PET/CT for the detection and characterization of pancreatic tumoursK Herrmann, M Erkan, M Dobritz, et al.
Scientific Reports|December 8, 2017
Apparent Diffusion Coefficient (ADC) predicts therapy response in pancreatic ductal adenocarcinomaM Trajkovic-Arsic, I Heid, K Steiger, et al.
Journal of Cancer Research and Clinical Oncology|August 26, 2020
Combined systemic inflammation score (SIS) correlates with prognosis in patients with advanced pancreatic cancer receiving palliative chemotherapyM Markus, A Abendroth, R Noureddine, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|June 23, 2020
The predictive and prognostic significance of cell-free DNA concentration in melanomaR Váraljai, S Elouali, S S Lueong, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|January 5, 2019
Neurotrophic tropomyosin receptor kinase (NTRK) and nerve growth factor (NGF) are not expressed in Caucasian patients with biliary tract cancers: pooled data from three independent cohortsC B Westphalen, A Preinfalk, S Kruger, et al.
ESMO Open|August 21, 2022
Multimodal survival prediction in advanced pancreatic cancer using machine learningJ Keyl, S Kasper, M Wiesweg, et al.
Journal of Nuclear Cardiology : Official Publication of the American Society of Nuclear Cardiology|September 25, 2020
Cardiac fibroblast activation detected by Ga-68 FAPI PET imaging as a potential novel biomarker of cardiac injury/remodelingJ Siebermair, M I Köhler, J Kupusovic, et al.
ESMO Open|May 6, 2023
Smaller panel, similar results: genomic profiling and molecularly informed therapy in pancreatic cancerT M Reissig, I Tzianopoulos, S-T Liffers, et al.
ESMO Open|March 19, 2024
Changes over time in the course of advanced pancreatic cancer treatment with systemic chemotherapy: a pooled analysis of five clinical trials from two decades of the German AIO study groupL Weiss, L E Fischer, V Heinemann, et al.
European Journal of Cancer (Oxford, England : 1990)|March 18, 2018
Efficacy of gemcitabine plus erlotinib in rash-positive patients with metastatic pancreatic cancer selected according to eligibility for FOLFIRINOX: A prospective phase II study of the 'Arbeitsgemeinschaft Internistische Onkologie'M Haas, J T Siveke, M Schenk, et al.
Pageof 3